Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties-Reference-Cited by-同舟云学术

Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties

Published:2022-12-21 Issue:6 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Corman Hannah N.¹²,Ross Jessica N.¹²^ORCID,Fields Francisco R.³,Shoue Douglas A.¹²,McDowell Mary Ann¹²,Lee Shaun W.¹²^ORCID

Affiliation:

1. University of Notre Dame, Department of Biological Sciences, Notre Dame, Indiana, USA

2. University of Notre Dame, Eck Institute for Global Health, Notre Dame, Indiana, USA

3. Johnson & Johnson Consumer Products Inc., Skillman, New Jersey, USA

Abstract

Leishmaniasis is a neglected tropical disease caused by protozoan parasites of the genus Leishmania . There are three primary clinical forms, cutaneous, mucocutaneous, and visceral, with visceral leishmaniasis being fatal if left untreated.

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

Indiana Clinical and Translational Sciences Institute

HHS | NIH | National Institute of General Medical Sciences

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.02658-22

Reference74 articles.

1. Diagnosis of leishmaniasis

2. The history of leishmaniasis

3. Leishmaniasis: current situation and new perspectives

4. Leishmaniasis Worldwide and Global Estimates of Its Incidence

5. Leishmaniasis: clinical syndromes and treatment

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Leishmania Promastigotes and Amastigotes Forms through Amino Acids and Peptides: A Promising Therapeutic Strategy;ACS Infectious Diseases;2024-07-01

2. Combating Antimicrobial Resistance by Employing Antimicrobial Peptides: Immunomodulators and Therapeutic Agents against Infectious Diseases;ACS Applied Bio Materials;2024-03-27

3. Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease;Pathogens;2023-07-15